Department of Military Affairs Tender by Indian Army (169538e2d)

Artemether 80 mg plus Lumefantrine 480 mg Tab,Artesunate 60 mg Inj,Beclomethasone Dipropionate 200

Goods
Qty:9,925

Tender Timeline

Tender Issue
May 12, 2025 at 10:26 AM

The DGLP MEDICINE 04 tender, identified by reference number 169538e2d, is officially issued by the Department of Military Affairs under the Ministry of Defence. This tender primarily focuses on the procurement of essential pharmaceuticals, specifically concentrations of Artemether 80 mg plus Lumefantrine 480 mg Tabs, Artesunate 60 mg Inj, and Beclomethasone Dipropionate 200 mcg metered doses.

Scope of Work and Objectives

The primary objective of the DGLP MEDICINE 04 tender is to ensure a streamlined supply chain of critical medications required by military health services. This tender includes the procurement of 9,925 units of medicines divided among the specified categories to maintain adequate health resources within military establishments and ensure the wellbeing of personnel.

Eligibility Criteria

To qualify for participation in this tender, bidders must meet certain eligibility criteria, including being a registered supplier of pharmaceutical products. Companies must demonstrate adequate experience in pharmaceutical manufacturing and supply, possess valid licenses for drug distribution, and comply with industry regulations.

Technical Requirements

The products provided under this tender must comply with rigorous technical specifications and quality standards to ensure safety and effectiveness. Bidders are required to submit product specifications, manufacturing process documentation, and performance data to substantiate their compliance with applicable standards.

Financial Requirements

Bidders must provide financial documents including proof of capability to fulfill the contract, bank statements, and any other financial guarantees required as part of the submission process. The financial health and stability of the bidding companies will be evaluated during the tender assessment.

Document Submission Details

Interested parties must ensure that all necessary documents are submitted according to specified submission methods. The bidding documentation should include technical proposals, financial statements, and any certifications pertinent to the pharmaceuticals offered. The submission formats accepted include digital documents in PDF and Word formats.

Special Provisions

The tender encourages participation from Micro, Small, and Medium Enterprises (MSEs) and startups. Special provisions may be in place to support these entities, including reduced financial barriers. This aligns with governmental initiatives aimed at promoting local enterprises and supporting entrepreneurial growth.

Evaluation Process

The evaluation and selection process for this tender will consist of a thorough assessment of the received bids based on compliance with eligibility and technical criteria, quality standards, and cost-effectiveness. Price evaluation will be conducted taking into account the overall value offered by the bidder. The results of the evaluation will be communicated to all participants promptly.

Delivery Locations

The required medicines are expected to be delivered to designated military healthcare facilities, with specific addresses provided upon successful bid acceptance. Companies should ensure that their logistics capabilities align with the delivery requirements specified in the tender.

Contact Information

For further inquiries related to this tender, potential bidders may seek clarification through the channels provided with the tender documentation. Direct contact details are typically included for the department or officials responsible for managing the tender.

This tender represents an opportunity for established and emerging pharmaceutical entities to contribute to military healthcare efforts by providing critical medicinal support. Bidders are encouraged to prepare comprehensive proposals that meet all outlined requirements to ensure successful participation in the procurement process.


Tender BOQ Items

11 Items
1.

Artemether 80 mg plus Lumefantrine 480 mg Tab

As per pdf

Qty:180
Unit:no
30
2.

Artesunate 60 mg Inj

As per pdf

Qty:30
Unit:amp vial
30
3.

Beclomethasone Dipropionate 200 mcg metered dose aerosol containing 200 metered doses

As per pdf

Qty:40
Unit:no
30
4.

Beclomethasone Dipropionate 50 mcg and Levosalbutamol 50 mcg per metred dose in CFC free MDI

As per pdf

Qty:45
Unit:no
30
5.

Beclomethasone Dipropionate nasal spray 50 mcg per dose metered dose 150 units

As per pdf

Qty:30
Unit:bott
30
6.

Betahistine Dihydrochloride 16mg Tab

As per pdf

Qty:600
Unit:no
30
7.

Betahistine Dihydrochloride 8mg Tab

As per pdf

Qty:3000
Unit:no
30
8.

Biotin 10mg Tab

As per pdf

Qty:1200
Unit:no
30
9.

Bisacodyl 5 mg Tab

As per pdf

Qty:3600
Unit:no
30
10.

Bisoprolol 2.5 mg Tab

As per pdf

Qty:600
Unit:no
30
11.

Bisoprolol 5 mg Tab

As per pdf

Qty:600
Unit:no
30

General Information

Item Category
Artemether 80 mg plus Lumefantrine 480 mg Tab , Artesunate 60 mg Inj , Beclomethasone Dipropionate 200 mcg metered dose aerosol containing 200 metered doses , Beclomethasone Dipropionate 50 mcg and Levosalbutamol 50 mcg per metred dose in CFC free MDI , Beclomethasone Dipropionate nasal spray 50 mcg per dose metered dose 150 units , Betahistine Dihydrochloride 16mg Tab , Betahistine Dihydrochloride 8mg Tab , Biotin 10mg Tab , Bisacodyl 5 mg Tab , Bisoprolol 2.5 mg Tab , Bisoprolol 5 mg Tab
Ministry Name
Organisation Name
City

Financial Information

Bid Offer Validity
180 (Days)

Evaluation and Technical Information

Inspection Required
No

Tender Documents

4 Documents
GeM-Bidding-7830182.pdfMain Document
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Similar Tenders

View All

Diclofenac 25 mg per ml 3 ml inj,lorazepam 2 mg per ml 2 ml inj,Dopamine HCl 40 mg per ml 5 ml inj,

GEM
Goods
Qty:16.9K
4 Files
Indian Army
KANGRA, HIMACHAL PRADESH
Boq › Boql
Diclofenac 25 mg per ml 3 ml inj , lorazepam 2 mg per ml 2 ml inj , Dopamine HCl 40 mg per ml 5 ml inj , Dextrose inj 25 per 25 ml inj , Amikacin sulphate 250 mg per 2 ml inj , Pantoprazole 40 mh inj , Meropenem 1 gm inj , Gentamycin sulphate inj IM IV 40 mg per ml 2 ml inj , Hyoscine Bromide inj 20 mg per ml 1 ml inj , Promethazine HCL 2 point 5 per 25 mg per ml inj 2 ml inj , Pheniramine Maleate inj 22point75 mg per ml amp of 2 ml , Frusemide 20 mg 2 ml inj , Phytomenadione vit K 1 ml inj , Metronidazole inj IV 500 mg per bott of 100 ml , Dexamethasone 4 point 4 2 ml inj , Mannitol 20 per 100 ml bott , Adrealine Tartrate 1 ratio 1000 1 ml inj , Sodium Bicarbonate 7 point 5 10 ml Amp , Etophylline BP 84 point 7 mg theophylline IP 25 point 3 mg per ml 2 ml inj , Inj Nitroglycerine 5 mg , Magnessium Sulphate 50 per W by V inj , Phenylepherine HCl 10 mg per ml inj , Lignocaine HCL solution 2 per for IV use 50 ml inj , Antispasmodic tab containing Mefenamic Acid 250 mg Dicyclomine HCL 10 mg , Cap Pre probiotic 4 or more organisms , Antacid Tab , Chlorzoxazone 500 mf Diclofenc 50 mg PCM 325 mg tab Cipzox , Calcium Carbonate 500 mg Tab , Metoclopeamide 10 mg Tab , Telmisartan 40 mg Tab , Omeprazole 20 mg Cap , Pantoprazole 40 mg Tab , Ranitidine 150 mg Tab , Dicyclomine 20 mg PCM 500 mg Tab , Ascorbic Acid 500 mg Tab , Acetazolamide 0 point25 mg Tab , Amlodipine besylate 5 mg Tab , Nifedipine Retard 20 mg Tab , Doxycycline Cap 100 mg , Domperidone 10 mg Tab , Frusemide 40 mg Tab , Metronidazole 400 mg Tab , Sodium Chloride 0 point 65 W V Nasal Drops 15 ml , Mometasone 0 point 1 per tube of 10 gm , Framycetin Sulphate BP 1 per crean 20 gm , Povidone Iodine 5 per bott of 100 ml , Beclomethasone 200 mcg cont 200 mtd doses , Levosalbutamol Aerosol pack of 200 mtd dose inhaler 50 mcg , Gamma Benzene Hexachloride 1 per cetrimide alcholic soln
May 13, 2025
June 3, 2025 at 8:00 PM
View Details

Frequently Asked Questions

The eligibility requirements include being a registered entity within the pharmaceutical sector, maintaining valid licenses for drug distribution, and having experience in manufacturing similar health products. Bidders must also comply with industry regulations to ensure the safety and efficacy of the medicines they offer.

All products submitted must conform to strict technical specifications and quality standards as outlined in the tender documentation. This includes verification of the manufacturing processes, adherence to safety protocols, and compliance with health regulations to ensure that all medications are effective and safe for military use.

Document submissions for the DGLP MEDICINE 04 tender must be made digitally. Accepted document formats typically include PDF and Word files. Bidders must ensure that all documentation is complete and adheres to the specified guidelines in the tender to avoid disqualification.

Bidders must provide details about payment terms during the submission process. Typically, performance security is set as a percentage of the contract value and must be furnished to ensure compliance with contract obligations and timely delivery of products.

Micro, Small, and Medium Enterprises (MSEs) can access special provisions in this tender that aim to reduce financial barriers for participation. These benefits may include simplified bidding processes, reduced performance securities, and active encouragement from the government to support local manufacturing endeavors aligned with national policies such as Make in India.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders